Suppr超能文献

相似文献

1
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.
J Natl Cancer Inst. 2012 Sep 19;104(18):1411-21. doi: 10.1093/jnci/djs328. Epub 2012 Aug 9.
2
Pioglitazone use and risk of bladder cancer: population based cohort study.
BMJ. 2016 Mar 30;352:i1541. doi: 10.1136/bmj.i1541.
5
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study.
Diabetologia. 2012 Jul;55(7):1953-62. doi: 10.1007/s00125-012-2538-9. Epub 2012 Mar 31.
7
Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
Cerebrovasc Dis. 2013;36(2):145-51. doi: 10.1159/000353679. Epub 2013 Sep 11.
8
Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes.
Medicine (Baltimore). 2016 Feb;95(6):e2786. doi: 10.1097/MD.0000000000002786.

引用本文的文献

1
Neuroendocrine tumors and diabetes mellitus: which treatment and which effect.
Endocrine. 2025 Apr;88(1):36-50. doi: 10.1007/s12020-024-04149-9. Epub 2025 Jan 3.
3
Cancer biology in diabetes update: Focusing on antidiabetic drugs.
J Diabetes Investig. 2024 May;15(5):525-540. doi: 10.1111/jdi.14152. Epub 2024 Mar 8.
4
The urothelial gene regulatory network: understanding biology to improve bladder cancer management.
Oncogene. 2024 Jan;43(1):1-21. doi: 10.1038/s41388-023-02876-3. Epub 2023 Nov 23.
5
6
SGLT-2 Inhibitors in Cancer Treatment-Mechanisms of Action and Emerging New Perspectives.
Cancers (Basel). 2022 Nov 25;14(23):5811. doi: 10.3390/cancers14235811.
7
The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment.
J Immunol Res. 2022 Aug 18;2022:2651790. doi: 10.1155/2022/2651790. eCollection 2022.
8
A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus.
Diabetes Metab J. 2022 Nov;46(6):855-865. doi: 10.4093/dmj.2021.0264. Epub 2022 Mar 8.
9
Cutaneous metastatic seeding as a sequela of nephrostomy catheter placement.
Radiol Case Rep. 2020 Dec 5;16(2):343-347. doi: 10.1016/j.radcr.2020.11.038. eCollection 2021 Feb.
10
Nuclear receptors in podocyte biology and glomerular disease.
Nat Rev Nephrol. 2021 Mar;17(3):185-204. doi: 10.1038/s41581-020-00339-6. Epub 2020 Sep 17.

本文引用的文献

3
Pioglitazone and bladder cancer: a population-based study of Taiwanese.
Diabetes Care. 2012 Feb;35(2):278-80. doi: 10.2337/dc11-1449. Epub 2011 Dec 30.
4
Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease.
Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1138-49. doi: 10.1002/pds.2203. Epub 2011 Aug 24.
5
Exposure to statins and risk of common cancers: a series of nested case-control studies.
BMC Cancer. 2011 Sep 26;11:409. doi: 10.1186/1471-2407-11-409.
6
Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2011 Aug 16;155(4):246-51. doi: 10.7326/0003-4819-155-4-201108160-00008.
7
Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.
Diabetologia. 2011 Aug;54(8):2009-15. doi: 10.1007/s00125-011-2171-z. Epub 2011 May 5.
10
Diabetes and risk of bladder cancer: evidence from a case-control study in New England.
Cancer. 2011 Apr 1;117(7):1552-6. doi: 10.1002/cncr.25641. Epub 2010 Nov 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验